| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.42 | 0.01 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |